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Influenza Vaccination in Children Having Chemotherapy for Cancer  
 
 
 Background  
Children having chemotherapy for cancer are prone to developing influenza 
infections. Influenza virus infection may lead to hospitalisation/ prolonged 
hospitalisation, interruption of treatment and other severe adverse outcomes 
such as death. While clinical guidelines recommend children that are being 
treated for cancer be vaccinated against influenza, evidence supporting this 
recommendation is unclear. 
 
 Objective/s  
The objectives of this review were to: (1) assess the efficacy of influenza 
vaccination in stimulating immunological response in children with cancer 
receiving chemotherapy, compared to other control groups; (2) assess the 
efficacy of influenza vaccination in preventing influenza infection; and (3) 
establish any adverse effects associated with influenza vaccines in children 
with cancer. 
 
 Intervention/Methods 
The review included seven clinical controlled trials (CCT) and one randomised 
controlled trial (RCT). In total, 708 participants aged below 18 years were 
included in the review. The mean age of participants in the chemotherapy 
groups and other control groups were comparable. 
 
- None of the included studies compared influenza vaccine to placebo or 
assessed any clinical outcomes. That is, influenza infection, 
hospitalisation and delay in chemotherapy were not reported as 
outcome measures in any of the included studies. 
- Five of these studies compared responses to influenza vaccines in 
children receiving chemotherapy for cancer, to those with cancer but 
not receiving chemotherapy.  
- Four of these studies compared influenza vaccines in children 
receiving chemotherapy for cancer, to healthy children and those with 
asthma. 
 
In five studies, loss to follow up was identified as a potential risk of bias. The 
only included RCT did not report the method of randomisation, clear allocation 
concealment or blinding. Attempts in gaining further information from trialists 
were made and were unsuccessful.   
 
 Results 
No meta-analysis was conducted due to the lack of RCTs. The review 
reported that influenza vaccines were safe to use without major adverse 
effects in this population, and immunological responses were observed in all 
included studies. Two studies reported adverse effects including mild local 
reactions and low-grade fever. None of the studies reported more severe or 
higher number of adverse effects in participants receiving chemotherapy 
compared to other control groups. Poorer immunological responses were 
observed in children receiving chemotherapy for cancer (four-fold rise of 25% 
to 52%) than those who were healthy (71% to 89%) / with asthma (63% to 
77%)/ children with cancer who did not receive chemotherapy over the last 
four weeks prior to vaccination (50% to 86%). However, no studies have 
compared vaccine to placebo, nor did they report any clinical outcomes. 
Concerning the use of different protocols, only one study compared two 
vaccination protocols in children with Acute Lymphoblastic leukaemia (ALL) 
on chemotherapy. No significant difference was found. 
 
 
 Conclusions 
The review reported the efficacy of influenza vaccination in stimulating 
immunological responses in children receiving chemotherapy for cancer. 
However, the lack of RCTs and studies investigating clinical outcomes make it 
impossible to assess the clinical benefits of influenza vaccinations in this 
patient group.  
 
  
 Implications for Practice 
Before further evidence is developed, clinicians need to consider the benefits 
and risks of influenza vaccination in children.   
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